NCT06954766View on ClinicalTrials.gov

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
Knee Osteoarthritis
Interventions
DEVICE

CKD-981(1)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE

CKD-981(2)

20 minutes per day, 5 days a week for 6 weeks.

DEVICE

Sham device

20 minutes per day, 5 days a week for 6 weeks.

DRUG

Reference Drug

QD for 6 weeks

DRUG

Placebo Drug

QD for 6 weeks

Trial Locations (1)

Unknown

RECRUITING

Wonju Severance Christian Hospital, Wŏnju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT06954766 - Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 | Biotech Hunter | Biotech Hunter